20 min
Podcast 1: JAK inhibitors and the evolving treatment landscape for atopic dermatitis Atopic Dermatitis Treatment Insights
-
- Education
Listen in on this short and engaging podcast to hear Professor Jacob Thyssen and Professor Jonathan Silverberg discuss recent approval indications of JAK inhibitors in Europe and the US to treat atopic dermatitis. In this session they cover the mode of action, safety and efficacy of JAK inhibitors, including clinical trial evidence, the differences in the adverse events between JAK inhibitor treatment options and a comparison between JAK inhibitors and other commonly prescribed systemic therapies.
Listen in on this short and engaging podcast to hear Professor Jacob Thyssen and Professor Jonathan Silverberg discuss recent approval indications of JAK inhibitors in Europe and the US to treat atopic dermatitis. In this session they cover the mode of action, safety and efficacy of JAK inhibitors, including clinical trial evidence, the differences in the adverse events between JAK inhibitor treatment options and a comparison between JAK inhibitors and other commonly prescribed systemic therapies.
20 min